as 12-20-2024 4:00pm EST
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | BOSTON |
Market Cap: | 77.0M | IPO Year: | 2020 |
Target Price: | $8.00 | AVG Volume (30 days): | 248.2K |
Analyst Decision: | Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -1.80 | EPS Growth: | N/A |
52 Week Low/High: | $1.82 - $12.51 | Next Earning Date: | 11-12-2024 |
Revenue: | $55,162,000 | Revenue Growth: | 16.08% |
Revenue Growth (this year): | 15.31% | Revenue Growth (next year): | 16.10% |
MASS Breaking Stock News: Dive into MASS Ticker-Specific Updates for Smart Investing
Business Wire
3 days ago
Simply Wall St.
a month ago
Simply Wall St.
a month ago
GuruFocus.com
a month ago
Zacks
a month ago
Business Wire
a month ago
GuruFocus.com
a month ago
Simply Wall St.
2 months ago
The information presented on this page, "MASS 908 Devices Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.